Comorbidities and seizures: Bone health

Gregory D. Cascino

doi:10.1007/978-3-030-59078-9_37

Comorbidities and seizures: Bone health

Gregory D. Cascino

Neurology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Patients with a seizure disorder receive antiseizure medication (ASM) and may experience idiosyncratic or dose-related treatment-emergent adverse effects. One important concern associated with ASM use is metabolic bone disease. Selected medical therapies have an increased incidence for bone health issues and may predispose to fractures. The combination of a gait disorder, balance issues, and falling also needs to be considered in individuals with metabolic bone disease. All patients receiving long-term antiseizure medications, regardless of diagnosis or seizure classification, need to have periodic evaluation for bone health.

Original language	English (US)
Title of host publication	Epilepsy Case Studies
Subtitle of host publication	Pearls for Patient Care: Second Edition
Publisher	Springer International Publishing
Pages	209-212
Number of pages	4
ISBN (Electronic)	9783030590789
ISBN (Print)	9783030590772
DOIs	https://doi.org/10.1007/978-3-030-59078-9_37
State	Published - Dec 19 2020

Keywords

Bone densitometry study
Fracture(s)
Metabolic bone disease
Osteoporosis
Vitamin D deficiency

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-030-59078-9_37

Cite this

@inbook{df73fd367e0447c9be124f8749d3e4a3,

title = "Comorbidities and seizures: Bone health",

abstract = "Patients with a seizure disorder receive antiseizure medication (ASM) and may experience idiosyncratic or dose-related treatment-emergent adverse effects. One important concern associated with ASM use is metabolic bone disease. Selected medical therapies have an increased incidence for bone health issues and may predispose to fractures. The combination of a gait disorder, balance issues, and falling also needs to be considered in individuals with metabolic bone disease. All patients receiving long-term antiseizure medications, regardless of diagnosis or seizure classification, need to have periodic evaluation for bone health.",

keywords = "Bone densitometry study, Fracture(s), Metabolic bone disease, Osteoporosis, Vitamin D deficiency",

author = "Cascino, {Gregory D.}",

year = "2020",

month = dec,

day = "19",

doi = "10.1007/978-3-030-59078-9_37",

language = "English (US)",

isbn = "9783030590772",

pages = "209--212",

booktitle = "Epilepsy Case Studies",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Comorbidities and seizures

T2 - Bone health

AU - Cascino, Gregory D.

PY - 2020/12/19

Y1 - 2020/12/19

N2 - Patients with a seizure disorder receive antiseizure medication (ASM) and may experience idiosyncratic or dose-related treatment-emergent adverse effects. One important concern associated with ASM use is metabolic bone disease. Selected medical therapies have an increased incidence for bone health issues and may predispose to fractures. The combination of a gait disorder, balance issues, and falling also needs to be considered in individuals with metabolic bone disease. All patients receiving long-term antiseizure medications, regardless of diagnosis or seizure classification, need to have periodic evaluation for bone health.

AB - Patients with a seizure disorder receive antiseizure medication (ASM) and may experience idiosyncratic or dose-related treatment-emergent adverse effects. One important concern associated with ASM use is metabolic bone disease. Selected medical therapies have an increased incidence for bone health issues and may predispose to fractures. The combination of a gait disorder, balance issues, and falling also needs to be considered in individuals with metabolic bone disease. All patients receiving long-term antiseizure medications, regardless of diagnosis or seizure classification, need to have periodic evaluation for bone health.

KW - Bone densitometry study

KW - Fracture(s)

KW - Metabolic bone disease

KW - Osteoporosis

KW - Vitamin D deficiency

UR - http://www.scopus.com/inward/record.url?scp=85149797197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85149797197&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-59078-9_37

DO - 10.1007/978-3-030-59078-9_37

M3 - Chapter

AN - SCOPUS:85149797197

SN - 9783030590772

SP - 209

EP - 212

BT - Epilepsy Case Studies

PB - Springer International Publishing

ER -

Comorbidities and seizures: Bone health

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this